was incorporated in 2015 and is headquartered in South San Francisco, California. To buy US shares you must first complete and return a US government. and changed its name to RAPT Therapeutics, Inc. View recent trades and share price information for Rapt Therapeutics Inc USD0.0001. Free forex prices, toplists, indices and lots more. The company was formerly known as FLX Bio, Inc. RAPT Therapeutics (RAPT) stock price, charts, trades & the US's most popular discussion forums. View RAPT Therapeutics, Inc.s Stock Price Close (Unadjusted) (Trading. It is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1 that are in the discovery stage of development. The stock price of Rapt Therapeutics Inc (NASDAQ: RAPT) increased by over 80 during intraday trading. RAPT Therapeuticss stock price close (unadjusted) (trading days only) is 35.43.
The company's lead inflammation drug candidate is RPT193 to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
#RAPT STOCK PRICE TRIAL#
Its lead oncology drug candidate is FLX475, an oral small molecule C-C motif chemokine receptor 4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. This suggests a possible upside of 93.1 from the stock's current price. On average, they expect RAPT Therapeutics' stock price to reach 60.17 in the next year. Their forecasts range from 49.00 to 72.00.
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. 6 Wall Street analysts have issued 12 month target prices for RAPT Therapeutics' stock.